Potential benefits of Chinese Herbal Medicine for elderly patients with cardiovascular diseases

Journal of Geriatric Cardiology

Volumn 10, Issue 4, 2013, Pages 305-309

  Luo, Jing ^a   Xu, Hao ^b   Chen, Ke Ji ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b XIYUAN HOSPITAL   (China)

Author keywords

Cardiovascular diseases; Chinese medicine; Elderly patients; Herb

Indexed keywords

CARDIOVASCULAR DISEASE; CHINESE MEDICINE; DIABETES MELLITUS; FOOD; GERIATRIC PATIENT; GINSENG; HERBAL MEDICINE; HOLISTIC CARE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MEDICINE; MORBIDITY; POLYPHARMACY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SALVIA MILTIORRHIZA; SYNDROME DIFFERENTIATION BASED TREATMENT; WESTERN MEDICINE;

EID: 84892752873     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.04.001     Document Type: Review

References (37)

1. National Center for Cardiovascular Diseases, China (NCCD). Report on Cardiovascular Diseases in China (2011). Encyclopedia of China Publishing House: Beijing, China, 2012;7-12.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.
3. Horton R. GBD 2010: understanding disease, injury, and risk. The Lancet 2012;380:2053-2054.
4. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012;380:2197-2223.
5. Chen KJ, Lv AP. Situation of Integrative Medicine in China: Results from a National Survey in 2004. Chin J Integr Med 2006;12:161-165.
6. World health organization. Traditional medicine strategy 2002-2005, 2002. Available from: http://whqlibdoc.who.int/hq/2002/WHO-EDM-TRM-2002.1.pdf. (Accessed 8th June 2013).
7. Ferreira AS, Lopes AJ. Chinese medicine pattern differentiation and its im-plications for clinical practice. Chin J Integr Med 2011;17:818-823.
8. Xu H, Chen KJ. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chin J Integr Med 2011;17:83-84.
9. Lambert ND, Ovsyannikova IG, Pankratz VS, et al. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines 2012;11:985-994.
10. Schmucker DL. Liver function and phase I drug metabolism in the elderly: a pa-radox. Drugs Aging 2001;18:837-851.
11. Lindeman RD. Changes in renal function with aging. Implications for treatment. Drugs Aging 1992;2:423-431.
12. Lesage J. Polypharmacy in geriatric patients. Nurs Clin North Am 1991;26:273-290.
13. Chen YT, Wang Y, Radford MJ, et al. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure. Am Heart J 2001;141:410-417.
14. Gattis WA, Larsen RL, Hasselblad V, et al. Is optimal angiotensinconverting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J 1998;136:43-48.
15. Howland RH. Effects of aging on pharmacokinetic and pharmacodynamic drug processes. J Psychosoc Nurs Ment Health Serv 2009;47:15-18.
16. White HD, Chew DP. Acute myocardial infarction. The Lancet 2008;372:570-584.
17. Eugene B. The treatment of acute myocardial infarction: the Past, the Present, and the Future. Eur Heart J Acute Cardiovasc Care 2012;1:9-12.
18. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 2007;49:1362-1368.
19. Wang JR, Zhou H, Yi XQ, et al. Total ginsenosides of Radix Ginseng modulates tricarboxylic acid cycle protein expression to enhance cardiac energy metabolism in ischemic rat heart tissues. Molecules 2012;17:12746-12757.
20. Li HX, Han SY, Ma X, et al. The saponin of red ginseng protects the cardiac myocytes against ischemic injury in vitro and in vivo. Phytomedicine 2012;19:477-483.
21. Zhou W, Ruigrok TJ. Protective effect of danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am J Chin Med 1990;18:19-24.
22. Liu Y, Yin HJ, Jiang YR, et al. Correlation between platelet Gelsolin and platelet activation level in acute myocardial infarction rats and intervention effect of effective components of chuanxiong rhizome and red peony root. Evid Based Complement Alternat Med 2013;985746.
23. Chen KJ, Shi DZ, Xu H, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin Med J (Engl) 2006;119:6-13.
24. Xu H, Gao ZY, Chen KJ. A prospective study on the diagnostic and therapeutic status and prognosis of 1864 elderly patients with coronary heart disease. Chinese Journal of Geriatrics 2008;27:617-622.
25. Shang QH, Xu H, Lu XY, et al. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of elderly patients. Chin J Integr Med 2011;17:669-674.
26. Du BM, Lu ZL, Wu YF, et al. China coronary secondary prevention study: conclusion in aged coronary heart disease patients with or without hypertension. Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases 2006;8:82-86.
27. Wu T, Harrison RA, Chen X, et al. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst Rev 2006;18:1-40.
28. Jia YL, Huang F, Zhang S, et al. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol 2012;157:330-340.
29. Hu XM, Liu F, Zheng CM, et al. Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy. Chin J Integr Med 2009;15:193-197.
30. Song XR, Hou SX. Research progress in the reversion of traditional Chinese medicine on multidrug resistance of tumor. Wu GL, Fan YS, Han YM, et al. Effect of Yangyin jiedu Huoxue Recipe on hormone withdrawal and disease activity in patients with systemic lupus erythematosus. Chin J Integr Tradit West Med 2009;29:780-782.
31. Lv AP, Ding XR, Chen KJ. Current Situation and Progress in Integrative Medicine in China. Chin J Integr Med 2008;14:234-240.
32. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new medical research council guidance. BMJ 2008;337:a1655.
33. Zhao J, Jiang P, Zhang W. Molecular networks for the study of TCM pharma-cology. Brief Bioinform 2012;11:417-430.
34. Terstappen GC, Reggiani A. In silico research in drug discovery. Trends Pharmacol Sci 2001;22:23-26.
35. Ma XH, Zheng CJ, Han LY, et al. Synergistic therapeutic actions of herbal in-gredients and their mechanisms from molecular interaction and network perspectives. Drug Discov Today 2009;14:579-588.
36. Hou JY. Pharmacology of Traditional Chinese Medicine; China Press of traditional Chinese Medicine: Beijing, China, 2002;21.
37. Wang L. Guidelines for the Selection of Therapeutic Food; China Light Industry Press: Beijing, China, 2000.